Search Results 941-950 of 19851 for Hepatitis b

  1. Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Mayo Clinic

    Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma ... hepatitis B core ...

  2. Hemochromatosis - Doctors and departments - Mayo Clinic

    Sumera I. Ilyas, M.B.B.S.. Transplant Hepatologist. Rochester, MN. Areas of focus: Hepatocellular carcinoma, Cirrhosis, Hepatitis C, Hepatitis B, ...

  3. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

    ... hepatitis B or hepatitis C infection. Subjects with a history of hepatitis infection must have cleared their infection as determined by standard serological ...

  4. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    Patient must be tested for hepatitis B within 28 days prior to randomization. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection.

  5. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    ... Hepatitis B, Portal hypertension, Hemo...chromatosis, Alcoholic hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary ...

  6. To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients - Mayo Clinic

    Donor or recipient with known hepatitis C infection (Hepatitis C Virus (HCV) ... hepatitis B are not excluded by this criterion. Primary focal segmental ...

  7. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV ...

  8. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies - Mayo Clinic

    hepatitis B surface antibody is present; or; hepatitis B DNA testing is negative and the patient is receiving hepatitis B reactivation prophylaxis with ...

  9. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

    Known active hepatitis B or C infection 20. Invasive fungal or viral infection (as per clinical judgment) 21. Known hypersensitivity or allergy to D or Q 22 ...

  10. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying new ways to diagnose and treat hepatitis C, with particular emphasis on optimal antiviral therapy ...